Home > Analytics > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Intrinsic Value | Fundamental Analysis

BOM : 524518     NSE : KREBSBIO    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Aug 19,2026
Price(EOD): ₹ 55.81
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 120.55 Cr
Value of ₹ 1 Lac invested in KREBS BIOCHEMICALS & INDUSTRIES
on Aug 20,2021 (price: ₹ 147.25)

₹ 1 L

₹ 0.38 L

1W : -3.8% 1M : 1.6% 1Y : -33.8%
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results
KREBS BIOCHEMICALS & INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
KREBS BIOCHEMICALS & INDUSTRIES -3.8% 1.6% -33.8%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -3.3% 15.7%
DIVIS LABORATORIES 0.3% 16.3% 44.3%
TORRENT PHARMACEUTICALS 2.8% -0.5% 37.1%
CIPLA -3.1% -1.2% -5.8%
DR REDDYS LABORATORIES -2.9% -3% -3.3%
MANKIND PHARMA -1.1% -7.2% -1.7%
LUPIN -1.8% -11.7% 14.5%
ZYDUS LIFESCIENCES -5.8% -3.4% 16.8%

FUNDAMENTAL ANALYSIS OF KREBS BIOCHEMICALS & INDUSTRIES

 
Fundamentals Score
[ Q(TTM): Jun2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF KREBS BIOCHEMICALS & INDUSTRIES

 
Valuation Score
[As on : Aug 19,2026 ]

Ratio Standalone
P/E
P/B
P/S
-8.54
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -14.10 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

-0.69
P/B Calculated based on Book Value of Rs -173.81 Cr
[Latest Year - Mar2026 - Standalone Results ]

4.77
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 26% undervalued companies ! Discover More →

FAIR VALUE OF KREBS BIOCHEMICALS & INDUSTRIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
NA (-ve EV)
76%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF KREBS BIOCHEMICALS & INDUSTRIES



KREBS BIOCHEMICALS & INDUSTRIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF KREBS BIOCHEMICALS & INDUSTRIES

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
-1.45
-1.62
-1.84
-1.64
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF KREBS BIOCHEMICALS & INDUSTRIES

Pledged Promoter Shares
0 %
As on : Jun2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF KREBS BIOCHEMICALS & INDUSTRIES

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
2.57%
195.28%
-6.24%
-6.24%
27.42%
139.63%
53.31%
53.31%
QtrlyTrend
4
Latest Qtr: Jun2026
Quarterly Result Analysis →


KREBS BIOCHEMICALS & INDUSTRIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KREBS BIOCHEMICALS & INDUSTRIES


Is KREBS BIOCHEMICALS & INDUSTRIES good for long term investment?

As on Aug 19,2026, the Fundamentals of KREBS BIOCHEMICALS & INDUSTRIES look Poor and hence it may not be good for long term investment ! See Financial Performance of KREBS BIOCHEMICALS & INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is KREBS BIOCHEMICALS & INDUSTRIES UnderValued or OverValued?

As on Aug 19,2026, KREBS BIOCHEMICALS & INDUSTRIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of KREBS BIOCHEMICALS & INDUSTRIES ?

As on Aug 19,2026, the Intrinsic Value of KREBS BIOCHEMICALS & INDUSTRIES is Rs. 31.65 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -69.00
Fair Value [Median EV / Sales Model] : Rs. -16.49
Fair Value [Median Price / Sales Model] : Rs. 31.65
Estimated Median Fair Value of KREBS BIOCHEMICALS & INDUSTRIES : Rs. 31.65

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is KREBS BIOCHEMICALS & INDUSTRIES trading at a Premium or Discount?

As on Aug 19,2026, KREBS BIOCHEMICALS & INDUSTRIES is trading at a Premium of 76% based on the estimates of Median Intrinsic Value!